TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 23,884 | 21,697 | 20,560 |
Financial expenses | 728 | 673 | 1,342 |
Earnings before taxes | 4,067 | -3,442 | -752 |
EBITDA | 4,294 | 3,791 | -407 |
Total assets | 25,141 | 23,823 | 28,707 |
Current assets | 15,635 | 10,061 | 8,802 |
Current liabilities | 5,278 | 5,055 | 6,107 |
Equity capital | 17,493 | 14,739 | 17,137 |
- share capital | 26 | 29 | 29 |
Employees (average) | 120 | 123 | 90 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 69.6% | 61.9% | 59.7% |
Turnover per employee | 199 | 176 | 228 |
Profit as a percentage of turnover | 17.0% | -15.9% | -3.7% |
Return on assets (ROA) | 19.1% | -11.6% | 2.1% |
Current ratio | 296.2% | 199.0% | 144.1% |
Return on equity (ROE) | 23.2% | -23.4% | -4.4% |
Change turnover | 3,944 | 1,518 | -4,596 |
Change turnover % | 20% | 8% | -18% |
Chg. No. of employees | -3 | 33 | -40 |
Chg. No. of employees % | -2% | 37% | -31% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.